Skip to content

CogLife 2.0 - Memory is quality of life

CogLife 2.0 - Memory is quality of life

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00030000
Enrollment
150
Registered
2023-01-25
Start date
2023-02-13
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00 F01 F02 F03 F06.7

Interventions

Group 1: Group 1: Subjects without any cognitive impairment: Physical-Training-Questionnaire, Freiburger Ernährungsprotokoll, C.I.R.S.-Questionaire, Social history, patient screening, activities of da

Sponsors

Uniklinik Köln - Zentrum für Innere Medizin II, Schwerpunkt klinische Altersforschung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Subject is 65 years or older 2) Subject is showing a subjective cognitive impairment OR subject is showing no cognitive impairment OR subject is showing a mild cognitive impairment 3) Subject is capable to give an informed consent regarding the participation in the study or has a legal representative 4) Subject is not suffering from a life threatening disease 5) Subject shows an CIRS-G-Score (Cumulative Illness Rating Scale-Geriatric) = 2 6) Subjects is not suffering from a neurological or psychiatric disease 7) Subject has an BMI between 18 and 30 8) Subject does not take any vitamin supplements 9) Subject is not vegetarian or vegan 10) Subject does not take any antioxidants

Exclusion criteria

Exclusion criteria: 1) Subject does not meet the inclusion criteria 2) Subject is not able to take part in the questioning due to barrier of language 3) Current substance abuse 4) Subject is suffering from a life threatening disease 5) Missing or not undertaken consent to take part in this study

Design outcomes

Primary

MeasureTime frame
Evaluation of the impact of metabolism products (metabolome, especially lipidoma) and the plasma lipid level on the cognitive functions of elderly subjects.

Secondary

MeasureTime frame
1) Evaluation of the MPI 2) Comparison of the undertaken tests A) cognitive performence tests B) metabolism products (metabolome, especially lipidoma) and plasma lipid level 3) Evaluation of physical fitness 1-year Follow-Up planned

Countries

Germany

Contacts

Public ContactAlexander Thimm

Uniklinik Köln, Schwerpunkt klinische Altersforschung

alexander.thimm@uk-koeln.de0049 176 52880602

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026